Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data

por Wanlapakorn, Nasamon, Suntronwong, Nungruthai, Phowatthanasathian, Harit, Yorsaeng, Ritthideach, Thongmee, Thanunrat, Vichaiwattana, Preeyaporn, Auphimai, Chompoonut, Wongsrisang, Lakkhana, Klinfueng, Sirapa, Sudhinaraset, Natthinee, Poovorawan, Yong
Publicado 2022

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

por Wanlapakorn, Nasamon, Suntronwong, Nungruthai, Phowatthanasathian, Harit, Yorsaeng, Ritthideach, Vichaiwattana, Preeyaporn, Thongmee, Thanunrat, Auphimai, Chompoonut, Srimuan, Donchida, Thatsanatorn, Thaksaporn, Assawakosri, Suvichada, Kanokudom, Sitthichai, Poovorawan, Yong
Publicado 2022

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults

por Yorsaeng, Ritthideach, Suntronwong, Nungruthai, Phowatthanasathian, Harit, Assawakosri, Suvichada, Kanokudom, Sitthichai, Thongmee, Thanunrat, Vichaiwattana, Preeyaporn, Auphimai, Chompoonut, Wongsrisang, Lakkhana, Srimuan, Donchida, Thatsanatorn, Thaksaporn, Klinfueng, Sirapa, Sudhinaraset, Natthinee, Wanlapakorn, Nasamon, Poovorawan, Yong
Publicado 2022